Human Papillomavirus (HPV) Infections
3
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Integrated Adolescent Health Package
Research Leaders
8 sponsors active, led by Institut d'Investigació Biomèdica de Bellvitge
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
33%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)
Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV
Research Network
Common Treatments
- Integrated Adolescent Health Package1
- Routine Government Health Services1
- Nonavalent Hpv Vaccine 9vhpvgardasil91
- Nonavalent Hpv Vaccine 9vhpv1
Active Sponsors
- Institut d'Investigació Biomèdica de Bellvitge1
- Catalan Institute of Health1
- Gavi, The Vaccine Alliance1
- Johns Hopkins Bloomberg School of Public Health1
- Hospital del Mar1
Top Investigators
Cancer Epidemiology Research Program (PREC), Catalan Institute of Oncology (ICO-Hospitalet)/Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
Cancer Epidemiology Research Program (PREC), Catalan Institute of Oncology (ICO-Hospitalet)/Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
Johns Hopkins University
Related Conditions
- Highrisk Hpv Any Strain1
- Hpv16 181
- Hpv1
- Human Papillomavirus Hpv Vaccines1
- Adolescent Health Services1